ABSTRACT: A number of Houttuynia cordata fermentation products are commercially available in Thailand. However, their anticancer activity remains to be investigated. In this study, the phenolic acid composition and anticancer activity of two commercialized H. cordata fermentation products were investigated. Reversed phase HPLC was used to identify and quantify phenolic acids. MTT and Annexin V staining assays were used to investigate antiproliferative and apoptosis induction activities, respectively. Seven phenolic acids including protocatechuic, p-hydroxybenzoic, vanillic, syringic, p-coumaric, ferulic, and sinapinic acids were detected in the water-soluble constituents of both fermentation products 1 and 2. Water-soluble constituents of fermentation product 2 containing a greater phenolic acid content were more effective than product 1 in inhibiting the growth of HeLa, HCT116, and HT29 cells in a dose-and time-dependent manner. The non-cancer cell line Vero cells appeared to be resistant to both fermentation products. The growth inhibitory effects of both fermentation products in HeLa, HCT116, and HT29 cells included induction of apoptosis. These results suggest that commercially available fermentation products of H. cordata contain several anticancer phenolic acids that may be beneficial in the treatment of human cancer.
Phenolic acid composition and anticancer activity against human cancer cell lines of the commercially available fermentation products of Houttuynia cordata 
INTRODUCTION
Mortality rate of Thai population caused by cancers ranks the top among other causes of death per 100 000 population 1 . Chemotherapy is an effective way to treat many types of cancers but the cost of treatment with powerful chemicals is a major public health concern in developing countries. Anti-cancer drugs used to treat patients often are expensive and most of them cause negative side effects, especially to normal cells that have a high proliferation rate, affecting most cancer patients. Cancer chemotherapy aims to cure the disease or to extend human life, however, most cancer patients confront suffering from both the disease itself and side effects induced by the treatment. The expensive cost of chemotherapeutic drugs is a dilemma for patients in low-income countries. Accordingly, a herbal medicine for cancer treatment is still an inevitable option.
Houttuynia cordata Thunb., a medicinal plant known in Thai as 'phlu khao', is generally used as a local vegetable in the northern and northeastern regions of Thailand. As a medicinal plant, it has been reported to possess important biological properties such as anticancer [2] [3] [4] [5] [6] [7] , antiviral 8, 9 , antioxidant 10, 11 , and antiinflammatory activities 12, 13 . In Thailand, many of H. cordata fermentation products are commercially available, however, the anticancer activity of these commercialized products remains to be investigated. Although anticancer activities of water and ethanolic extracts of the plant have been studied intensively, little is known regarding anticancer activity of the fermentation products. The ethanolic extract of yeastand ethanol-fermented H. cordata has been shown to exhibit a greater extent of toxicity to human leukaemia cell lines than the non-fermented plant 2 . In addition, Kwon and Ha demonstrated that fermentation process increase the flavonoid content and fermentation products of H. cordata inhibit the growth of hepatocellular carcinoma cell line (HepG2 cells) 14 . Four flavonoid compounds (rutin, hyperoside, quercitrin, and quercetin) were reported as major bioactive ingredients in H. cordata 15, 16 . Two new compounds, houttuynoside A and houttuynamide A, and 38 known compounds have been also identified from a whole plant methanolic extract 17 . Nonetheless, phenolic acid composition of a plant fermentation product has not been investigated. For the above reason, the present study examines the antiproliferation and apoptosis induction of human cervical cancer cell line (HeLa cells), human colon cancer cell lines (HT29 and HCT116 cells), and a non-cancer cell line (Vero cells) by two commercially available fermentation products of H. cordata. In addition, some phenolic acids are identified and their contents determined in the water-soluble constituents of the plant fermentation products.
MATERIALS AND METHODS

Materials
Fermentation product 1 (FP1) was obtained from a local herbal shop in Khon Kaen province, Thailand. Fermentation product 2 (FP2) was obtained from Prolac (Thailand) Co., Ltd. in Lamphun province, Thailand. The information on their plant ingredients and serving suggestion were obtained from the label on their containers (Table 1) . Most chemicals including the pure standards of phenolic acids were obtained from Sigma-Aldrich Corporation (St. Louis, MO, USA), whereas m-hydroxybenzaldehyde and p-hydroxybenzoic acid were purchased from Fluka (Buchs, Switzerland) and Acros Organics (Geel, Belgium), respectively.
Preparation of lyophilized fermentation products
To determine and compare phenolic acid composition and anticancer activity of the two commercially available fermentation products, lyophilized powders of H. cordata fermentation products were prepared. Twenty millilitres of each fermentation product were filtered through Whatman grade no. 1 filter paper and centrifuged at 5000g for 15 min. The supernatant containing water-soluble constituents was lyophilized to obtain a crude lyophilized fermentation product. Lyophilization of 20 ml of water-soluble constituents gave yields of 1.54 ± 0.06 g and 0.25 ± 0.04 g for FP1 and FP2, respectively.
Phenolic acid extraction
The lyophilized fermentation product (water-soluble constituents) of 1 g was extracted in 200 ml of 70% methanol and stirred continuously for 12 h at room temperature. The mixture was filtered through Whatman grade no. 1 filter paper. The filtrate was evaporated to 60 ml by a rotary evaporator. Further extraction of free and esterified phenolic acids from the 60 ml-filtrate was performed as previously described 18 .
HPLC analysis
The individual phenolic acids in lyophilized fermentation products were identified by using a Waters HPLC system as previously described 18 . The amount of individual phenolic acids in samples was determined by using a standard curve between the concentration of phenolic acid standards (0.5, 1, 2, 3, 4, and 5 µg) (x-axis) and the ratio between peak areas of the phenolic acid standard and the internal standard (m-hydroxybenzaldehyde; 1 µg) (y-axis).
Cell culture
HeLa, HCT116, HT29, and Vero cells were obtained from Dr P. Picha (National Cancer Institute, Bangkok, Thailand), Dr O. Tetsu (University of California, San Francisco, US), and Dr S. Barusrux (Khon Kaen University, Khon Kaen, Thailand). All cell lines were cultured at 37°C in a humidified atmosphere with 5% CO 2 and maintained in RPMI-1640 medium supplemented with 10% foetal bovine serum, penicillin (100 U/ml), and streptomycin (100 µg/ml) (Gibco-BRL).
Antiproliferative activity assay
To assess cell growth inhibition, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay 19 was used. Briefly, cells at a cell density of 10 4 cells/well were seeded in a 96-well plate and incubated for 24 h. Different concentrations (0.32-7.70 mg/ml) of lyophilized fermentation products were added to the cells and incubated for 48 and 72 h. Vehicle control groups were added with double distilled water. After exposing the cells to the lyophilized fermentation products, the medium was removed, and the cells were incubated with MTT (Sigma Chemical Co., St Louis, MO) (0.5 mg/ml in PBS) for 2 h. DMSO was used to dissolve the formazan dye, which was detected by a microtitre plate reader (Bio-Rad Laboratories, Hercules, CA, USA) at 550 nm. A reference wavelength used in this study was at 655 nm. The production of formazan dye was proportional to the number of viable cells.
Apoptosis analysis
Vybrant Apoptosis Assay Kit #2 (Molecular Probes, Invitrogen Corporation, Carlsbad, CA, USA.) was used to assess apoptosis induction activity according to the manufacturer's instructions. Briefly, cells were seeded at 1.2 × 10 6 cells/4 ml in a 5.2-cm dish, incubated for 24 h, and treated with different concentrations of the samples for 24 h. Cells were harvested and stained with Alexa Fluor 488-Annexin V and propidium iodide (PI) as previously described 19 . The flow cytometry results were compared with conventional cell count and morphology under a fluorescence microscope.
Statistical analysis
Data from three replicated experiments are expressed as mean ± standard deviation (SD). Statistical analysis was carried out using SPSS 11.5 for windows (SPSS Corporation, Chicago, IL, USA). Significant differences between vehicle controls and sample treated cells were analysed by using one-way ANOVA with Duncan's post hoc test. The p < 0.05 was set for statistical significance.
RESULTS
After lyophilization, the yields of 1 ml-water-soluble constituents of FP1 and FP2 were 77.0 ± 3.0 and 12.5 ± 2.0 mg, respectively.
In this study, the lyophilized water-soluble constituents of both fermentation products were used to investigate their phenolic acid composition and anticancer activity.
Phenolic acid composition
Some phenolic compounds in the extract of this plant have been described [15] [16] [17] , however, the phenolic acid composition in the commercialized fermentation products has not yet been determined. Preliminary separation and identification of individual phenolic compounds in water-soluble constituents of two commercialized fermentation products were conducted by reversed phase HPLC. Fig. 1 shows typical chromatograms of phenolic acid standards and phenolic extracts of two lyophilized fermentation products (water-soluble constituents). Seven phenolic acids including protocatechuic, p-hydroxybenzoic, vanillic, syringic, p-coumaric, ferulic, and sinapinic acids, were identified in the water-soluble constituents of both FP1 (Fig. 1b) and FP2 (Fig. 1c) . Among the identified phenolic acids of FP1 and FP2, the predominant phenolic acids were vanillic and syringic acids, respectively ( Table 2 ). The confirmation of sample peaks was obtained by liquid chromatography-mass spectrometry analysis (data not shown). However, two major sample peaks of FP2 remains to be identified (Fig. 1c) . According to HPLC results, the total amount of phenolic acids in water-soluble constituents www.scienceasia.org Values are means ± SD of three experiments performed in duplicate. Different superscript letters within the same column indicate significant differences (p < 0.05).
of FP2 appeared to be greater than that of FP1 ( Fig. 1 and Table 2 ). Among all identified phenolic acids in water-soluble constituents of FP1, only p-coumaric and ferulic acids were detected in a greater quantity than in FP2 (Table 2) .
Fermentation product effect on the proliferation of human cancer cell lines
The lyophilized water-soluble constituents of two commercially available fermentation products were investigated for their antiproliferative activity by MTT method, a conventional tetrazolium-based colorimetric cell proliferation assay. In this study, three human cancer cell lines (HeLa, HCT116, and HT29 cells) and a non-cancer cell line (Vero cells) were used. As shown in Fig. 2 , lyophilized water-soluble constituents of both fermentation products inhibited the proliferation of all cancer cell lines tested in a concentration-and time-dependent manner. The lyophilized water-soluble constituent of FP2 demonstrated a greater efficacy in killing all cancer cell lines tested at both 48-and 72-h exposures (Fig. 2b,  Fig. 2d, and Fig. 2f ). The lyophilized water-soluble constituent of FP2 at less than 2 mg/ml was not cytotoxic to a non-tumourous cell line (Fig. 2h) . Based on an IC 50 (half maximal inhibitory concentration) of greater than 8 mg/ml at both 48-and 72-h exposures, the lyophilized water-soluble constituent of FP1 was considered non-cytotoxic to a non-cancer cell line (Fig. 2g) .
Fermentation product effect apoptotic induction
To further confirm that induction of apoptosis underlies antiproliferative effect of the two commercially available fermentation products, their capacity to induce apoptosis in cancer cell lines was examined. As shown in Fig. 3a , the lyophilized water-soluble constituent of FP2 exhibited a dose-dependent induction of apoptosis in cervical cancer cell line (HeLa cells) for 24-h exposure time in which early apoptotic cells (panels Q4) were increased up to 21% and 37% at concentrations of 4 and 6 mg/ml, respectively. In contrast, the treatment of HeLa cells with FP1 for 24 h resulted in the increase of early apoptotic cells only 6% and 6% at concentrations of 4 and 6 mg/ml, respectively. Both fermentation products demonstrated a greater efficacy on apoptosis induction of HCT116 and HT29 cells (Fig. 3b) . Apparently, FP2 exhibited a greater efficacy than FP1 on apoptosis induction of all cancer cell lines tested. FP1 and FP2 were the most effective in inducing apoptosis in HT29 and HCT116 cells, respectively. The non-cancer cell line (Vero cells) appeared to be resistant to an induction of apoptosis by each fermentation product (Fig. 3b ). These results suggest that H. cordata fermentation products suppress the growth of HeLa, HCT116, and HT29 cells at least in part through induction of apoptosis.
Effect of phenolic acids on cell proliferation
Some identified phenolic acids including p-coumaric, ferulic, and sinapinic acids have been previously shown to inhibit the growth of some cancer cell lines 18, 20, 21 . To further confirm that these identified phenolic acids underlie the antiproliferative effect found in the two commercially available fermentation products, the antiproliferative activities of p-coumaric, ferulic, and sinapinic acids against all three cancer cell lines were examined. The MTT assay (Table 3) show that p-coumaric, ferulic, and sinapinic acids could inhibit the growth of HeLa, HCT116, and HT29 cells at millimolar concentrations. p-Coumaric acid exhibited the greatest antiproliferative activity against all three cancer cell lines. Notably, all three phenolic acids were less toxic to the non-cancerous Vero cell line. This finding suggested that p-coumaric, ferulic, and sinapinic acids may underpin, at least in part, anticancer activity of the H. cordata fermentation products. 
DISCUSSION
The expensive cost of cancer chemotherapy afflicts many patients in developing countries. The use of herbal medicine for cancer treatment is therefore still an inevitable option in low-income countries. Poor patients struggle to save their lives using traditional medicinal plants containing unknown active ingredients. A number of phenolic compounds were identified from a whole plant methanolic extract of H. cordata 17 , including protocatechuic, p-hydroxybenzoic, and vanillic acids. Consistently, these phenolic compounds were also detected in both water-soluble constituents of FP1 and FP2 (Fig. 1) . We have investigated the profiles of phenolic acids in water-soluble constituents of the fermentation products because they represent water-soluble crude extracts of the two fermentation products normally consumed by patients and healthy consumers as a dietary supplement. To our knowledge, this is the first time that phenolic acid profiles of commercially available H. cordata fermentation products have been described. Although phenolic acid profiles of the two fermentation products appears to be similar ( Fig. 1) , a difference in their phenolic acid contents was observed. This difference may be due to different manufacturing processes. Furthermore, the difference may also be due to the presence of a K. pandurata Roxb. medicinal plant (15%; w/w) in H. cordata FP1 (Table 1) . Future studies are needed to elucidate the phenolic acid profiles of other commercially available fermentation products to provide more comprehensive data, which would be beneficial for both cancer patients and healthy consumers. Based on our findings that H. cordata fermentation products possessed antiproliferative activity (Fig. 2) , one may envision a role for the plant fermentation products in a folk medicine for cancer treatment. As a single-drug treatment, water-soluble constituents of the plant fermentation products were not appreciably potent, however, the combination treatment with other anticancer drugs/medicinal plants may lead to the development of effective therapeutic strategies. The lower phenolic acid content of FP1 (Table 2 ) may contribute to its lower efficacy in antiproliferative activity compared to FP2 (Fig. 2) . Recently, sinapinic acid has been shown to possess histone deacetylase (HDAC) inhibitory activity and inhibit the growth of HeLa, HT29 and HCT116 cells 18 . Protocatechuic acid has been reported to exhibit antiproliferative activity against HL-60 leukaemia cells through induction of apoptosis 22 . p-Coumaric acid detected in water-soluble constituents of both FP1 and FP2 has been shown to inhibit the growth of HCT15 and HT29 cells by inducing apoptosis through ROS-mitochondrial pathway 20 , inhibit the growth of Caco-2 cells by inducing a G2/M phase cell cycle arrest 23 , and inhibit tumour growth in vivo through the inhibition of angiogenesis 24 . Syringic acid has been shown to exhibit cytotoxic activity against A549 lung cancer cells 25 , whereas ferulic acid was reported to have antiproliferative and apoptosis induction activities towards a bladder cancer cell line (T24 cells) 21 . Consistently, p-coumaric, ferulic, and sinapinic acids were found to exhibit antiproliferative activity against HeLa, HCT116 and HT29 cells at millimolar concentrations, and p-coumaric acid was the most effective compounds in killing both cervical cancer cells (HeLa cells) and colon cancer cells (HCT116 and HT29 cells) (Table 3) . Interestingly, sinapinic 18 , p-coumaric 26 , and ferulic acids were all found to possess HDAC inhibitory activity (unpublished data), and one could imagine that HDAC inhibition by these compounds may lead to hyperacetylation of histone proteins in cancer cells. Although the link between hyperacetylation and apoptosis is not fully understood, treatments with HDAC inhibitors usually lead to apoptosis induction 27 . Notably, inhibition of HDAC activity in cancer cells is a promising mechanism for cancer therapy 27 . The presence of the abovementioned phenolic acids in both FP1 and FP2 therefore may, at least in part, underpin their anticancer activity. There was no published record in PubMed regarding the effective cytotoxic activity of p-hydroxybenzoic and vanillic acids, however, the derivatives of p-hydroxybenzoic acid exhibited both HDAC inhibitory and anticancer activities 28 . Nonetheless, the possibility that other unidentified compounds ( Fig. 1 ) and flavonoids 15, 16 found in this plant might underpin the antiproliferative activity of the plant fermentation products cannot be excluded.
Induction of cancer cell apoptosis is a beneficial mechanism for cancer treatment. In this study, the externalized phosphatidylserine, a key "eat-me" signal of apoptotic cells 29 , was detected by a combined Annexin V/PI dual staining assay to confirm the cancer cell death via apoptotic mode. FP2 showed a greater apoptotic activity than FP1 in all cancer cell lines tested (Fig. 3) , suggesting that manufacturing process dramatically affected the quality of plant fermentation products. Sinapinic, p-coumaric, and ferulic acids have been shown to induce apoptosis of cancer cells 18, 20, 21 , thus they may at least in part contribute to apoptosis-induction capacity of H. cordata fermentation products.
In conclusion, the results in this report demonstrated that water-soluble constituents of two commercially available fermentation products had different anticancer activity and their antiproliferative activity seem to correspond to the amount and composition of phenolic acids. The growth inhibitory effect on a cervical cancer cell line (HeLa cells) and colon cancer cell lines (HCT116 and HT29 cells) of both fermentation products is in accordance with their capability to induce cancerous cell apoptosis. Further investigation will provide more details about flavonoid content, HDAC inhibitory activity, and anticancer activity in combination with other anticancer drugs of commercially available fermentation products. Theoretically, our findings may validate the use of H. cordata fermentation products as alternative medicine in cancer treatment.
